Home / Author Archives: Market Watch (page 3085)

Author Archives: Market Watch

Biogen ups investment in biosimilars

Biogen Inc. said it plans to make a $100 million upfront payment to Samsung Bioepis to acquire the rights to commercialize biosimilar versions of Lucentis and Eylea, two blockbuster eye drugs. Samsung Bioepis is a joint venture founded in 2012 ...

Read More »